New Polish study confirms levofloxacin is effective in CAP patients who have not responded to other antibiotics
A study carried out by researchers in Warsaw, Poland, have shown that levofloxacin is both a safe and effective treatment of community-acquired pneumonia for patients who have failed to respond to other antibiotics.
The group investigated consisted of 11 males and 14 females with an average age of 70 +/- 17.5 years. As out-patients, their CAP had failed to respond to a number of antibiotics and their condition was severe enough to warrant admission to hospital. There they were given i.v. levofloxacin 500 mg, twice a day, for 7 days. Complete regression of the CAP was obtained in 16 patients with partial regression in another 6. Adverse events were mild. The authors conclude that 500 mg levofloxacin, given i.v. twice a day for 7 days, is both a safe and effective treatment for patients who have failed to respond to other antibiotics.
Pneumonol. Alergol. Pol. 2006;74(1):77-9.
Source : http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=